S 2 Ep 4 Nathalie Riebel - CEO Oncospire episode artwork

EPISODE · Jan 24, 2025 · 38 MIN

S 2 Ep 4 Nathalie Riebel - CEO Oncospire

from She Leads Biotech · host Sharron Cox

In this conversation, CEO of Oncospire Nathalie Riebel, shares her journey from aspiring veterinarian to a leader in clinical research and cancer advocacy. We discuss her work in oncology, particularly head and neck cancer.  Advancements in cancer treatment technologies, and the role of AI in clinical trials. Nathalie emphasizes the significance of mentorship, leadership, and the evolving landscape of clinical operations, particularly for women in biotech. She also shares her vision for her new company and the importance of internships in fostering future talent in the industry. Chapters 00:00 Introduction and Background in Head and Neck Cancer 05:00 Career Journey and Transition to Clinical Research 10:03 Influential Figures and Leadership in Clinical Operations 15:00 The Evolution of Clinical Operations and AI's Role 20:13 Leadership Philosophy and Team Dynamics 25:36 Current Projects and Future Aspirations 31:50 Advice for Future Generations in Clinical Research

Episode metadata supplied by the publisher feed · Published Jan 24, 2025

Embed this episode

Ready to play

S 2 Ep 4 Nathalie Riebel - CEO Oncospire

0:00 38:20

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of She Leads Biotech?

This episode is 38 minutes long.

When was this She Leads Biotech episode published?

This episode was published on January 24, 2025.

Can I download this She Leads Biotech episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!